Brand : FLOPADEX

Flopadex 8/Mg 30/Hard G Cap

64.05

Sku : I-033433
Key features
Flopadex is a prescription medication used to improve urination in men with benign prostatic hyperplasia (enlarged prostate). How to use: The recommended dose is 8 mg Capsule once daily and for some population 4 mg capsule is recommended. Caution & Warnings: Intraoperative Floppy Iris Syndrome: the initiation of Sildosin is not recommended in patients for whom cataract surgery is scheduled. Discontinuing treatment with an alpha 1 blockers 1-2 weeks prior to cataract surgery has been recommended but the benefits and duration of stopping the therapy prior to cataract surgery has not been established. Orthostatic effects: the incidence of orthostatic effects with silodosin is very low. However, a reduction in blood pressure can occur in individual patients in rare cases to syncope. Renal impairment: the use of silodosin in patient with severe renal impairment (CLCR>30ml/min) is not recommended. Hepatic impairment: the use in severe hepatic impairment is not recommended. Carcinoma of prostate: patients thought to have BPH should be examined prior to starting therapy with Silodosin to rule out the presence of Carcinoma of the prostate. Sodium: the medicinal product contains less than 1 mmol sodium (23mg) per capsule, that’s to say essentially “sodium free” Ingredients: Silodosin 8 mg.

Description

Flopadex is a prescription medication used to improve urination in men with benign prostatic hyperplasia (enlarged prostate). How to use: The recommended dose is 8 mg Capsule once daily and for some population 4 mg capsule is recommended. Caution & Warnings: Intraoperative Floppy Iris Syndrome: the initiation of Sildosin is not recommended in patients for whom cataract surgery is scheduled. Discontinuing treatment with an alpha 1 blockers 1-2 weeks prior to cataract surgery has been recommended but the benefits and duration of stopping the therapy prior to cataract surgery has not been established. Orthostatic effects: the incidence of orthostatic effects with silodosin is very low. However, a reduction in blood pressure can occur in individual patients in rare cases to syncope. Renal impairment: the use of silodosin in patient with severe renal impairment (CLCR>30ml/min) is not recommended. Hepatic impairment: the use in severe hepatic impairment is not recommended. Carcinoma of prostate: patients thought to have BPH should be examined prior to starting therapy with Silodosin to rule out the presence of Carcinoma of the prostate. Sodium: the medicinal product contains less than 1 mmol sodium (23mg) per capsule, that’s to say essentially “sodium free” Ingredients: Silodosin 8 mg.

Medical Disclaimer

The information in this product description is drawn from trusted pharmaceutical sources and is provided for general health education only. It is not a substitute for professional medical advice, diagnosis or treatment. Always read the leaflet inside the medicine pack and consult your pharmacist or doctor before starting, changing or stopping any medication. Almujtama Pharmacy accepts no liability for reliance on this information in place of direct medical advice.